Skip to main content
Log in

Labordiagnostischer Leitfaden zur Abklärung von Funktionsstörungen und Erkrankungen der Schilddrüse

  • Leitlinien
  • Published:
Wiener klinische Wochenschrift Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Literatur

  • Dietlein M, Dressler J, Grünwald F, Joseph K, Leisner B, Moser E, Reiners C, Rendl J, Schicha H, Schneider P, Schober O (2003) Leitlinie zur Schilddrüsendiagnostik (Version 2). Nuklearmedizin 3: 109–115

    Google Scholar 

  • Tunbridge WM, Evered DC, Hall R, Appleton D, Brewis M. Clark F, Evans JG, Young E, Bird T, Smith PA (1077) The spectrum of thyroid disease in a community: the Wickham survey. Clin Endocrinol (Oxf) 7: 481–493

    Article  Google Scholar 

  • Vanderpump MP, Tunbridge WM, French JM, Appleton D, Bates D, Clark F, Grinmley Evans J, Hasan DM, Rodgers H, Tunbridge F, et al (1995) The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham survey. Clin Endocrinol (Oxf) 43: 55–68

    Article  CAS  Google Scholar 

  • Bundesgesetz über den Verkehr mit Speisesalz (Speisesalzgesetz) StF: BGBl. Nr. 112/1963; idF: 1990: BGBl. Nr. 288/1990; idF: BGBl. I Nr. 115/1999

  • Weissel M (2003) Legal augmentation of iodine content in table salt from 10 to 20 mg KI/kg: documented effects a decade later. Exp Clin Endocrinol Diabetes 111 (4): 187–190

    Article  PubMed  CAS  Google Scholar 

  • Heinisch M, Kumnig G, Asbock D, Mikosch P, Gallowitsch HJ, Kresnik E, Gomez I, Unterweger O, Lind P (2002) Goiter prevalence and urinary iodide excretion in a formerly iodine-deficient region after introduction of statutory lodization of common salt. Thyroid 12: 809–814

    Article  PubMed  CAS  Google Scholar 

  • Belin RM, Ladenson PW, Robinson KA, Powe NR (2002) Development and use of evidence-based clinical practice guidelines for thyroid diseases. Endocrinol Metab Clin North Am 31: 795–817

    Article  PubMed  Google Scholar 

  • Mostbeck A, Galvan G, Bauer P, Eber O, Atefie K, Dam K, Feichtinger H, Fritzsche H, Haydl H, Kohn H, Konig B, Koriska K, Kroiss A, Lind P, Markt B, Maschek W, Pesl H, Ramschak-Schwarzer S, Riccabona G, Stockhammer M, Zechmann W (1998) The incidence of hyperthyroidism in Austria from 1987 to 1995 before and after an increase in salt iodization in 1990. Eur J Nucl Med 25: 367–374

    Article  PubMed  CAS  Google Scholar 

  • Canaris GJ, Manowitz NR, Mayor G, Ridgway EC (2000) The Colorado thyroid disease prevalence study. Arch Intern Med 160: 526–534

    Article  PubMed  CAS  Google Scholar 

  • Belin RM, Astor BC, Powe NR Ladenson PW (2004) Smoke exposure is associated with a lower prevalence of serum thyroid autoantibodies and thyrotropin concentration elevation and a higher prevalence of mild thyrotropin concentration suppression in the third National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab 89: 6077–6086

    Article  PubMed  CAS  Google Scholar 

  • Hollowell JG, Staehling NW, Flanders WD, Hannon WH, Gunter EW, Spencer CA, Braverman LE (2002) Serum TSH, T4, and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab 87: 489–499

    Article  PubMed  CAS  Google Scholar 

  • Bacher-Stier C, Riccabona G, Totsch M, Kemmler G, Oberaigner W, Moncayo R (1997) Incidence and clinical characteristics of thyroid carcinoma after iodine prophylaxis in an endemic goiter country. Thyroid 7 (5): 733–741

    PubMed  CAS  Google Scholar 

  • Gomez Segovia I, Gallowitsch HJ, Kresnik E, Kumnig G, Igerc I, Matschnig S, Stronegger WJ, Lind P (2004) Descriptive epidemiology of thyroid carcinoma in Carinthia, Austria: 1984–2001. Histopathologic features and tumor classification of 734 cases under elevated general iodination of table salt since 1990: population-based age-stratified analysis on thyroid carcinoma incidence. Thyroid 14 (4): 277–286

    Article  PubMed  CAS  Google Scholar 

  • Statistik Austria, Gesundheit, Krebsregister (2002) www.statistik.at/fachbereich_03/krebserkrankungen.shtml

  • Vanderpump MP, Ahlquist JA, Franklyn JA, Clayton RN (1996) Consensus statement for good practice and audit measures in the management of hypothyroidism and hyperthyroidism. BMJ 313: 539–544

    PubMed  CAS  Google Scholar 

  • Ladenson PW, Singer PA, Ain KB, Bagchi N, Bigos ST, Levy EG, Smith SA, Daniels GH, Cohen HD (2000) American Thyroid Association guidelines for detection of thyroid dysfunction. Arch Intern Med 160: 1573–1575

    Article  PubMed  CAS  Google Scholar 

  • Helfand M, Redfern CC (1998) Clinical guideline, part 2. Screening for thyroid disease: an update. American College of Physicians Ann Intern Med 129: 144–158

    CAS  Google Scholar 

  • Cooper DS (1998) Subclinical thyroid disease: a Clinicians perspective (editorial). Ann Intern Med 129: 135–138

    PubMed  CAS  Google Scholar 

  • Demers LM, Spencer CA (2003) Laboratory support for the diagnosis and monitoring of thyroid disease. NACB Laboratory Medicine Practical Guidelines. Thyroid 13: 1–126

    Article  Google Scholar 

  • Sasse EA, Doumas BT, Miller WG, D'Orazio P, Eckfeldt JH, Evans SA, Graham GH, Meyers GL, Parson PJ, Stanton NV (2000) How to define and determine reference intervals in the clinical laboratory; Approved Guideline, 2nd ed, CLSI C28–A2

  • Beckett G, MacKenzie F (2007) Thyroid guidelines – are thyroid-stimulating hormone assays fit for purpose? Ann Clin Biochem 44: 203–208

    Article  PubMed  Google Scholar 

  • Völzke H, Lüdemann J, Robinson DM, Spieker KW, Schwahn C, Kramer A, John U, Meng W (2003) The prevalence of undiagnosed thyroid disorders in a previous iodine-deficient area. Thyroid 13: 803–810

    Article  PubMed  CAS  Google Scholar 

  • Zöphel K, Wunderlich G, Grüning Th, Koch R, Döge H, Kotzerke J (2005) Where does subclinical hypothyroidism start? Nuklearmedizin 44: 56–61

    PubMed  Google Scholar 

  • Dickey RA, Wartofsky L, Feld S (2005) Optimal thyrotropin level: normal ranges and reference intervals are not equivalent. Thyroid 15: 1035–1039

    Article  PubMed  CAS  Google Scholar 

  • Wartofsky L, Dickey RA (2005) The evidence for a narrower thyrotropin reference range is compelling. J Clin Endocrinol Metab 90: 5483–5488

    Article  PubMed  CAS  Google Scholar 

  • Brabant G, Beck-Peccoz P, Larzab B, Laurberg J, Orgiazzi J, Sabolcs I, Weetmann AP, Wiersinga WM (2006) Is there a need to redefine the upper normal limit of TSH? Eur J Endocrinol 154: 633–637

    Article  PubMed  CAS  Google Scholar 

  • Surks MI, Goswami G, Daniels GH (2005) The thyrotropin reference range should remain unchanged. J Clin Endocrinol Metab 90: 5489–5496

    Article  PubMed  CAS  Google Scholar 

  • American Association of Clinical Endocrinologists [28] (2002) American Association of Clinical Endocrinologists medical guidelines for clinical practice for the evaluation and treatment of hyperthyroidism and hypothyroidism. Endocr Pract 8: 457–469

    Google Scholar 

  • Pescovitz OH, Eugster EE (2004) Paediatric endocrinology. Lippincott Williams & Wilkins, Philadelphia

    Google Scholar 

  • Ochi Y, Hamazu M, Kajita Y, Nagata A (2002) Demonstration of anti-TSH antibody in TSH binding inhibitory immunoglobulin-positive sera of patients with Graves' disease. Clin Endocrinol 56: 405–412

    Article  CAS  Google Scholar 

  • Spencer CA, Schwarzbein D, Guttler RB, LoPresti JS, Nicoloff JT (1993) Thyrotropin (TSH)-releasing hormone stimulation test responses employing third and fourth generation TSH assays. J Clin Endocrin Metab 76: 494–498

    Article  CAS  Google Scholar 

  • Elminger MW, Kühnel W, Lambrecht H-G, Ranke MB (2001) Reference intervals from birth to adulthood for serum thyroxine (T4), trijodthyroinine (T3), free T3, free T4, thyroxine binding globulin (TBG) and thyrotropin (TSH). Clin Chem Lab Med 39: 973–979

    Article  Google Scholar 

  • Liappis N, Schlebusch H, Knapp M (1992) Referenzwerte für die Konzentration von freiem Trijodthyronin (FT3), Trijodthyronin (TT3), freiem Thyroxin (FT4), Thyroxin (TT4) und Thyroxin-bindendem Globulin (TBG) im Nabelschnurblutserum. Klin Pädiatr 204: 34–36

    PubMed  CAS  Google Scholar 

  • Liappis N, Schlebusch H, Van Perejés M, Berg I (1991) Referenzwerte für die Konzentration des freien Thyroxins, des freien Trijodthyronins und des Thyroxin-bindenden Globulins im Blutserum euthyreoter Kinder. Klin Pädiatr 203: 113–115

    Article  PubMed  CAS  Google Scholar 

  • Institute for Reference Materials and Measurement (IRMM): Reference Material Thyreoglobulin BCR-457, Geel, Belgien. www.irmm.jrc.be/html/reference_materials_catalogue/catalogue/index.htm

  • Snider RH, Nylen ES, Becker KL (1997) Procalcitonin and its component peptides in systemic inflammation: immunochemical characterization. J Investig Med. 45: 552–560

    PubMed  Google Scholar 

  • d'Herbomez M, Caron P, Bauters C, Cao CD, Schlienger JL, Sapin R, Baldet L, Carnaille B, Wémeau JL; French Group GTE (Groupe des Tumeurs Endocrines) (2007) Reference range of serum calcitonin levels in humans: influence of calcitonin assays, sex, age, and cigarette smoking. Eur J Endocrinol 157: 749–755

    Article  PubMed  CAS  Google Scholar 

  • Vierhapper H, Raber W, Bieglmayer C, Kaserer K, Weinhausl A, Niederle B (1997) Routine measurement of plasma calcitonin in nodularthyroid diseases. J Clin Endocrinol Metab 82: 1589–1593

    Article  PubMed  CAS  Google Scholar 

  • Borchhardt KA, Heinzl H, Gressl A, Hörl WH, Kaserer K, Sunder-Plassmann G (2006) Calcitonin concentrations in patients with chronic kidney disease and medullary thyroid carcinoma or c-cell hyperplasia. Kidney Internat 70: 2014–2020

    CAS  Google Scholar 

  • Bieglmayer C, Niederle B, Vierhapper H (2002) Interference causes false high calcitonin levels with a commercial assay. J Endocrinol Invest 25:197

    PubMed  CAS  Google Scholar 

  • Tommasi M, Brocchi A, Cappellini A, Raspati S, Mannelli M (2001) False serum calcitonin high levels using a non-competitive two-site IRMA. J Endocrinol Invest 24: 356–360

    PubMed  CAS  Google Scholar 

  • Feldt-Rasmussen U, Schleusener H, Carayon P (1994) Meta-analysis evaluation of the impact of thyrotropin receptor antibodies on long term remission after medical therapy of Graves' disease. J Clin Endocrinol Metab 78: 98–102

    Article  PubMed  CAS  Google Scholar 

  • Glinoer D, de Nayer P, Bex M, and the Belgian Collaborative Study Group on Graves' Disease (2001) Effects of L-thyroxine administration, TSH-receptor antibodies and smoking on the risk of recurrence in Graves' hyperthyroidism treated with antithyroid drugs: a double blind prospective randomized study. Eur J Endocrinol 144: 475–483

    Article  PubMed  CAS  Google Scholar 

  • Oosterhuis WP, Bruns DE, Watine J, Sandberg S, Horvath AR (2004) Evidence-based guidelines in laboratory medicine: principles and methods. Clin Chem 50: 806–818

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Mathias M. Müller.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bieglmayer, C., Buchinger, W., Födinger, M. et al. Labordiagnostischer Leitfaden zur Abklärung von Funktionsstörungen und Erkrankungen der Schilddrüse. Wien Klin Wochenschr 120, 370–382 (2008). https://doi.org/10.1007/s00508-008-0984-7

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00508-008-0984-7

Navigation